Asia-Pacific Medical Cannabis Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Apr 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 450
  • No of Figures: 51

Asia-Pacific Medical Cannabis Market, By Product (Oil, Dried Medical Cannabis, Medical Cannabis Capsules, Vape Pen, Whole Flower, Creams & Moisturizer, Ground Flower, Patch, Mask & Serum, Cleanser, Others), Source (Natural, Synthetic), Species (Sativa, Hybrid, Cannabis Indica), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, Cannabigerol (CBG), Cannabinol, Others), Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease, Epilepsy, Depression and Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood, Others), Route of Administration (Oral Solutions and Capsules, Smoking, Topicals, Vaporizers, Others), End User (Homecare Settings, Hospital and Rehab Centers, Pharmaceutical Industry, Research and Development Centers, Others), Distribution Channel (B2C, B2B), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028

Asia-Pacific Medical Cannabis Market

Market Analysis and Insights: Asia-Pacific Medical Cannabis Market

The medical cannabis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 27.3% in the forecast period of 2021 to 2028 and is expected to reach USD 12,070.43 million by 2028.

Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has wide range of application in treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS and Alzheimer’s among others.

The use of cannabis as medicine is not rigorously tested due to the government restrictions and resulting in limited clinical research to define the efficacy of cannabis in medical and clinical applications. However, preliminary studies suggests that cannabis can reduce vomiting and nausea in chemotherapy patients and helps in increasing the appetite.

The increased medicinal use of cannabis and controlled legalization and use of cannabis in various industries are driving the growth of the market. Advanced methodologies present in the field are also propelling the growth of the Asia-Pacific medical cannabis market.

The medical cannabis market provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the medical cannabis market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Medical Cannabis Market

Asia-Pacific Medical Cannabis Market Scope and Market Size

The medical cannabis market is categorized into eight notable segments which are based on the product, source, species, derivatives, application, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the medical cannabis market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, mask & serum, cleanser and others. In 2021, oil segment is expected to dominate the medical cannabis market due to high technology adoption by key players in the market.
  • On the basis of source, the medical cannabis market is segmented into synthetic and natural. In 2021, synthetic segment is expected to dominate the medical cannabis market because of increasing healthcare expenditure.
  • On the basis of species, the medical cannabis market is segmented into cannabis indica, sativa and hybrid. In 2021, cannabis indica segment is expected to dominate the medical cannabis market because of increased medicinal use of cannabis.
  • On the basis of derivatives, the medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, cannabinol, cannabigerol (CBG) and others. In 2021, cannabidiol (CBD) segment is expected to dominate the medical cannabis market due to increasing demand of medical marijuana products in the market.
  • On the basis of application, the medical cannabis market is segmented into Alzheimer’s disease, appetite loss, cancer, epilepsy, autism, mental health conditions, multiple sclerosis, pain management, nausea, muscle spasms, arthritis, elevate mood, depression and sleep disorders, anxiety and others. In 2021, Alzheimer’s disease segment is expected to dominate the medical cannabis market because of increasing R&D activities.
  • On the basis of route of administration, the medical cannabis market is segmented into oral solutions and capsules, smoking, vaporizers, topicals and others. In 2021, oral solutions and capsules segment is expected to dominate the medical cannabis market because of rising prevalence of chronic diseases.
  • On the basis of end user, the medical cannabis market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital and rehab centers and others. In 2021, pharmaceutical industry segment is expected to dominate the medical cannabis market because of increasing geriatric population and prevalence of chronic diseases.
  • On the basis of distribution channel, the medical cannabis market is segmented into B2B and B2C. In 2021, B2B segment is expected to dominate the medical cannabis market because of increasing demand of cannabis for medical and clinical purposes.

Medical Cannabis Market Country Level Analysis

The medical cannabis market is analysed and market size information is provided by the country, product, source, species, derivatives, application, route of administration, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific medical cannabis market report are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific.

Australia is dominating in the Asia-Pacific medical cannabis market because of the strong presence of market players in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

New Product Launches by Manufacturers is Creating New Opportunities for Players in the Medical Cannabis Market

The medical cannabis market also provides you with detailed market analysis for every country growth in aesthetic industry with medical cannabis market sales, impact of advancement in the medical cannabis market and changes in regulatory scenarios with their support for the medical cannabis market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Medical Cannabis Market Share Analysis

The medical cannabis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to medical cannabis market.

Some of the major players operating in the medical cannabis market are Tilray, Elixinol Asia-Pacific Limited, Medical Marijuana, Inc., Extractas, Peace Naturals Project Inc., BOL Pharma, PharmaHemp, Kiehl’s (A Subsidiary of L'ORÉAL), Althea Company Pty Ltd (A Subsidiary of Althea Group Holdings Limited), Apothecanna, Zenabis Asia-Pacific Ltd, Cresco Labs, IDT Australia, MEDIFARM, Greenwich Biosciences, Inc., MediPharm Labs Inc., THC Asia-Pacific Group Limited, Seed Cellar, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Crop King Seeds, BARNEY'S FARM, and Aphria Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. 

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of medical cannabis market.

For instance,

  • In December 2020, Aphria Inc. announced that it has entered in an agreement with Tilray to combine their business and will create the world’s largest Asia-Pacific cannabis company. This will help the company to further diversify its market in coming years.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the medical cannabis market which also provides the benefit for organisation to improve their offering for medical cannabis market.

Customization Available: Asia-Pacific Medical Cannabis Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 ANNUAL COST OF CULTIVATION:

TABLE 2 ANNUAL COST OF MANUFACTURING:

TABLE 3 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED

TABLE 26 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY ANXIETY, BY REGION, 2021-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC MUSCLE SPASMS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC CANCER IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 ASIA-PACIFIC ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 42 ASIA-PACIFIC ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 43 ASIA-PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 44 ASIA-PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 45 ASIA-PACIFIC DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 46 ASIA-PACIFIC DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 ASIA-PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 48 ASIA-PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 ASIA-PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 50 ASIA-PACIFIC AUTISM IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 52 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 53 ASIA-PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 54 ASIA-PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET , BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 ASIA-PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY PAIN MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)

TABLE 65 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SOURCE, 2019-2028 (USD MILLION)

TABLE 66 ASIA-PACIFIC NATURAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 67 ASIA-PACIFIC SYNTHETIC IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 68 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES, 2019-2028 (USD MILLION)

TABLE 69 ASIA-PACIFIC SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 70 ASIA-PACIFIC HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 71 ASIA-PACIFIC CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 72 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 73 ASIA-PACIFIC ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 74 ASIA-PACIFIC SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 75 ASIA-PACIFIC TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 76 ASIA-PACIFIC VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 77 ASIA-PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 78 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 79 ASIA-PACIFIC HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 80 ASIA-PACIFIC HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 81 ASIA-PACIFIC REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 82 ASIA-PACIFIC PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 83 ASIA-PACIFIC RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 84 ASIA-PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 85 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 86 ASIA-PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 87 ASIA-PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 88 ASIA-PACIFIC B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 89 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

TABLE 90 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 91 ASIA-PACIFIC TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 92 ASIA-PACIFIC SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 93 ASIA-PACIFIC SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 94 ASIA-PACIFIC DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 95 ASIA-PACIFIC TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 96 ASIA-PACIFIC CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 97 ASIA-PACIFIC SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 98 ASIA-PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 99 ASIA-PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 100 ASIA-PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 101 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 102 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 103 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 104 ASIA-PACIFIC CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 105 ASIA-PACIFIC TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 106 ASIA-PACIFIC CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 107 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 108 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 109 ASIA-PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 110 ASIA-PACIFIC MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 111 ASIA-PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 112 ASIA-PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 113 ASIA-PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 114 ASIA-PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 115 ASIA-PACIFIC ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 116 ASIA-PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 117 ASIA-PACIFIC DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 118 ASIA-PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 119 ASIA-PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 120 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 121 ASIA-PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 122 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 123 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 124 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 125 ASIA-PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 126 AUSTRALIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 127 AUSTRALIA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 128 AUSTRALIA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 129 AUSTRALIA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 130 AUSTRALIA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 131 AUSTRALIA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 132 AUSTRALIA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 133 AUSTRALIA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 134 AUSTRALIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 135 AUSTRALIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 136 AUSTRALIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 137 AUSTRALIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 138 AUSTRALIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 139 AUSTRALIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 140 AUSTRALIA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 141 AUSTRALIA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 142 AUSTRALIA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 143 AUSTRALIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 144 AUSTRALIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 145 AUSTRALIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 146 AUSTRALIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 147 AUSTRALIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 148 AUSTRALIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 149 AUSTRALIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 150 AUSTRALIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 151 AUSTRALIA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 152 AUSTRALIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 153 AUSTRALIA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 154 AUSTRALIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 155 AUSTRALIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 156 AUSTRALIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 157 AUSTRALIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 158 AUSTRALIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 159 AUSTRALIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 160 AUSTRALIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 161 AUSTRALIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 162 THAILAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 163 THAILAND TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 164 THAILAND SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 165 THAILAND SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 166 THAILAND DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 167 THAILAND TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 168 THAILAND CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 169 THAILAND SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 170 THAILAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 171 THAILAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 172 THAILAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 173 THAILAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 174 THAILAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 175 THAILAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 176 THAILAND CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 177 THAILAND TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 178 THAILAND CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 179 THAILAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 180 THAILAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 181 THAILAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 182 THAILAND MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 183 THAILAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 184 THAILAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 185 THAILAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 186 THAILAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 187 THAILAND ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 188 THAILAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 189 THAILAND DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 190 THAILAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 191 THAILAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 192 THAILAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 193 THAILAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 194 THAILAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 195 THAILAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 196 THAILAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 197 THAILAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 198 SOUTH KOREA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 199 SOUTH KOREA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 200 SOUTH KOREA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 201 SOUTH KOREA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 202 SOUTH KOREA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 203 SOUTH KOREA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 204 SOUTH KOREA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 205 SOUTH KOREA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 206 SOUTH KOREA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 207 SOUTH KOREA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 208 SOUTH KOREA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 209 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 210 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 211 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 212 SOUTH KOREA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 213 SOUTH KOREA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 214 SOUTH KOREA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 215 SOUTH KOREA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 216 SOUTH KOREA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 217 SOUTH KOREA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 218 SOUTH KOREA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 219 SOUTH KOREA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 220 SOUTH KOREA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 221 SOUTH KOREA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 222 SOUTH KOREA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 223 SOUTH KOREA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 224 SOUTH KOREA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 225 SOUTH KOREA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 226 SOUTH KOREA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 227 SOUTH KOREA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 228 SOUTH KOREA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 229 SOUTH KOREA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 230 SOUTH KOREA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 231 SOUTH KOREA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 232 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 233 SOUTH KOREA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 234 JAPAN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 235 JAPAN TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 236 JAPAN SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 237 JAPAN SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 238 JAPAN DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 239 JAPAN TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 240 JAPAN CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 241 JAPAN SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 242 JAPAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 243 JAPAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 244 JAPAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 245 JAPAN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 246 JAPAN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 247 JAPAN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 248 JAPAN CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 249 JAPAN TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 250 JAPAN CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 251 JAPAN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 252 JAPAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 253 JAPAN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 254 JAPAN MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 255 JAPAN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 256 JAPAN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 257 JAPAN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 258 JAPAN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 259 JAPAN ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 260 JAPAN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 261 JAPAN DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 262 JAPAN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 263 JAPAN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 264 JAPAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 265 JAPAN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 266 JAPAN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 267 JAPAN MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 268 JAPAN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 269 JAPAN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 270 CHINA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 271 CHINA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 272 CHINA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 273 CHINA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 274 CHINA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 275 CHINA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 276 CHINA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 277 CHINA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 278 CHINA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 279 CHINA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 280 CHINA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 281 CHINA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 282 CHINA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 283 CHINA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 284 CHINA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 285 CHINA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 286 CHINA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 287 CHINA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 288 CHINA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 289 CHINA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 290 CHINA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 291 CHINA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 292 CHINA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 293 CHINA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 294 CHINA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 295 CHINA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 296 CHINA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 297 CHINA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 298 CHINA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 299 CHINA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 300 CHINA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 301 CHINA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 302 CHINA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 303 CHINA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 304 CHINA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 305 CHINA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 306 SINGAPORE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 307 SINGAPORE TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 308 SINGAPORE SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 309 SINGAPORE SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 310 SINGAPORE DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 311 SINGAPORE TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 312 SINGAPORE CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 313 SINGAPORE SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 314 SINGAPORE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 315 SINGAPORE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 316 SINGAPORE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 317 SINGAPORE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 318 SINGAPORE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 319 SINGAPORE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 320 SINGAPORE CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 321 SINGAPORE TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 322 SINGAPORE CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 323 SINGAPORE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 324 SINGAPORE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 325 SINGAPORE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 326 SINGAPORE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 327 SINGAPORE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 328 SINGAPORE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 329 SINGAPORE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 330 SINGAPORE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 331 SINGAPORE ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 332 SINGAPORE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 333 SINGAPORE DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 334 SINGAPORE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 335 SINGAPORE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 336 SINGAPORE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 337 SINGAPORE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 338 SINGAPORE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 339 SINGAPORE MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 340 SINGAPORE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 341 SINGAPORE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 342 INDIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 343 INDIA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 344 INDIA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 345 INDIA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 346 INDIA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 347 INDIA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 348 INDIA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 349 INDIA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 350 INDIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 351 INDIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 352 INDIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 353 INDIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 354 INDIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 355 INDIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 356 INDIA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 357 INDIA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 358 INDIA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 359 INDIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 360 INDIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 361 INDIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 362 INDIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 363 INDIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 364 INDIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 365 INDIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 366 INDIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 367 INDIA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 368 INDIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 369 INDIA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 370 INDIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 371 INDIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 372 INDIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 373 INDIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 374 INDIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 375 INDIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 376 INDIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 377 INDIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 378 MALAYSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 379 MALAYSIA TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 380 MALAYSIA SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 381 MALAYSIA SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 382 MALAYSIA DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 383 MALAYSIA TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 384 MALAYSIA CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 385 MALAYSIA SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 386 MALAYSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 387 MALAYSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 388 MALAYSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 389 MALAYSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 390 MALAYSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 391 MALAYSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 392 MALAYSIA CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 393 MALAYSIA TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 394 MALAYSIA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 395 MALAYSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 396 MALAYSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 397 MALAYSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 398 MALAYSIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 399 MALAYSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 400 MALAYSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 401 MALAYSIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 402 MALAYSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 403 MALAYSIA ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 404 MALAYSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 405 MALAYSIA DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 406 MALAYSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 407 MALAYSIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 408 MALAYSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 409 MALAYSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 410 MALAYSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 411 MALAYSIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 412 MALAYSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 413 MALAYSIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 414 PHILIPPINES MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 415 PHILIPPINES TYPE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 416 PHILIPPINES SOURCE IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 417 PHILIPPINES SPECIES IN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 418 PHILIPPINES DRIED MEDICAL CANNABS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 419 PHILIPPINES TYPE IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 420 PHILIPPINES CONCENTRATES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 421 PHILIPPINES SPECIES IN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 422 PHILIPPINES VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 423 PHILIPPINES WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 424 PHILIPPINES GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

TABLE 425 PHILIPPINES MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2028 (USD MILLION)

TABLE 426 PHILIPPINES MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2028 (USD MILLION)

TABLE 427 PHILIPPINES MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 428 PHILIPPINES CANNABIDIOL (CBD) MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 429 PHILIPPINES TETRAHYDROCANNABINOL (THC)/DELT-8-TETHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 430 PHILIPPINES CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2028 (USD MILLION)

TABLE 431 PHILIPPINES MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 432 PHILIPPINES PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 433 PHILIPPINES ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 434 PHILIPPINES MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 435 PHILIPPINES NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 436 PHILIPPINES APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 437 PHILIPPINES CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 438 PHILIPPINES ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 439 PHILIPPINES ALZHEIMER’S DISEASE/MIGRANES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 440 PHILIPPINES EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 441 PHILIPPINES DEPRESSION AND SLEEP DISRODER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 442 PHILIPPINES MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 443 PHILIPPINES AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 444 PHILIPPINES MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 445 PHILIPPINES ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

TABLE 446 PHILIPPINES MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION)

TABLE 447 PHILIPPINES MEDICAL CANNABIS MARKET, BY END USER, 2021-2028 (USD MILLION)

TABLE 448 PHILIPPINES MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 449 PHILIPPINES B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

TABLE 450 REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions